A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ML / mucosal

[Related PubMed/MEDLINE]
Total Number of Papers: 21
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ML  (>> Co-occurring Abbreviation)
Long Form:   mucosal
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Mucosal and mucocutaneous leishmaniasis in Iran from 1968 to 2018: a narrative review of clinical features, treatments, and outcomes. CL, MCL, VL
2019 What makes mucosal and anergic diffuse cutaneous leishmaniases so clinically and immunopathogically different? A review in Brazil. ACL, DCL
2018 Early Suppression of Macrophage Gene Expression by Leishmania braziliensis. CL, DL
2018 Favorable responses to treatment with 5 mg Sbv/kg/day meglumine antimoniate in patients with American tegumentary leishmaniasis acquired in different Brazilian regions. ATL, MA
2018 Molecular epidemiology and in vitro evidence suggest that Leishmania braziliensis strain helps determine antimony response among American tegumenary leishmaniasis patients. ATL, CL, DL
2017 Evaluation of a hypothetical protein for serodiagnosis and as a potential marker for post-treatment serological evaluation of tegumentary leishmaniasis patients. ELISA, SLA, TL
2017 Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013). ATL, IL, MA, NIID
2016 American tegumentary leishmaniasis: T-cell differentiation profile of cutaneous and mucosal forms-co-infection with Trypanosoma cruzi. CL
2016 Insulin-like growth factor-I serum levels and their biological effects on Leishmania isolates from different clinical forms of American tegumentary leishmaniasis. ATL, IGF, IGFBP-3
10  2016 New approaches from nanomedicine for treating leishmaniasis. CL, VL
11  2015 Leishmaniases diagnosis: an update on the use of immunological and molecular tools. PCR, VL
12  2014 Interleukin 32gamma (IL-32gamma) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10. ATL, IL-32, IL-32gamma, PBMC, TNF
13  2014 Recombinant Leishmania infantum heat shock protein 83 for the serodiagnosis of cutaneous, mucosal, and visceral leishmaniases. ELISA, VL
14  2013 Detection of Leishmania RNA virus in Leishmania parasites. CL, DCL, LRV
15  2012 Wound healing genes and susceptibility to cutaneous leishmaniasis in Brazil. CPC, tagSNPs
16  2011 Immunoregulatory and Effector Activities in Human Cutaneous and Mucosal Leishmaniasis: Understanding Mechanisms of Pathology. CL
17  2010 CXCR1 and SLC11A1 polymorphisms affect susceptibility to cutaneous leishmaniasis in Brazil: a case-control and family-based study. FBAT
18  2005 Flow cytometric analysis of cellular infiltrate from American tegumentary leishmaniasis lesions. ---
19  2004 Zinc/copper imbalance reflects immune dysfunction in human leishmaniasis: an ex vivo and in vitro study. LCL, VL
20  2003 Antibody subclass profile against Leishmania braziliensis and Leishmania amazonensis in the diagnosis and follow-up of mucosal leishmaniasis. IFAT, La, Lb
21  1995 Cytotoxicity in human mucosal and cutaneous leishmaniasis. LU, PBMC